Imagion Biosystems (ASX:IBX) enters trading halt ahead of breast cancer study
Imagion Biosystems (ASX:IBX) has entered a trading halt as it plans and executes a capital raise.
| Change | ||
| S&P/ASX Sm. Ords. | |||
| All Ordinaries | |||
| S&P/ASX 100 |
| NGY | NUENERGY GAS LIMITED | 4.6¢ | 24.3% |
| PKY | PATHKEY.AI LTD | 2.8¢ | 21.7% |
| BLG | BLUGLASS LIMITED | 26.0¢ | 20.9% |
| MNC | MERINO & CO. LIMITED | 8.5¢ | 29.2% |
| ABE | AUSTRALIAN BOND EXCHANGE HOLDINGS LIMITED | 1.5¢ | 25.0% |
| SRL | SUNRISE ENERGY METALS LIMITED | $6.43 | 18.4% |